4d Molecular Therapeutics, INC Form 4 insider transactions
NASDAQ
Form 4: 4D Molecular Therapeutics Chief Legal Officer Scott Bizily Executes Stock Option and Sells Shares
Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.
NASDAQ
Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.
NASDAQ
Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.